Lei Feng

1.2k citations
72 papers · 867 indexed · h-index 18
Topics
Circular RNAs in diseases (5 papers)Cancer-related Molecular Pathways (4 papers)RNA modifications and cancer (4 papers)
Journals
Nature CommunicationsSHILAP Revista de lepidopterologíaPLoS ONE
Partner nations
ChinaUnited StatesFrance

In The Last Decade

Lei Feng

69 papers receiving 850 citations

Peers

Lei Feng
Comparison fields: 5 of 105
  • Molecular Biology 363
  • Cancer Research 166
  • Surgery 140
  • Pulmonary and Respiratory Medicine 127
  • Oncology 96
Replace Rong Hu with:
Rong Hu China
Weiming Zhao China
Li Pang China
Bin Cao China
Kejia Wang China
Mahvash Sadeghi Iran
Yukinori Koyama Japan
Feng Xiao China
Yuguang Zhao China
Lei Feng relative to Rong Hu China Rong Hu's profile →
Citations per field
00.5×4.1×
Rong Hu · 1×
Citations per year

Countries citing papers authored by Lei Feng

Since Specialization
Citations

This map shows the geographic impact of Lei Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Feng more than expected).

Fields of papers citing papers by Lei Feng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lei Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Feng. The network helps show where Lei Feng may publish in the future.

Co-authorship network of co-authors of Lei Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Lei Feng. A scholar is included among the top collaborators of Lei Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Feng. Lei Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 3
4 1
5 1
6 1
7 2
8 3
9 5
10 5
11 1
12 8
13 4
14 8
15
Effects of AQP4 and KCNJ10 Gene Polymorphisms on Drug Resistance and Seizure Susceptibility in Chinese Han Patients with Focal Epilepsy
1
16 1
17 1
18 1
19 4
20 52

About Lei Feng

Lei Feng is a scholar working on Otorhinolaryngology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 72 papers that have together received 867 indexed citations. Recurring topics across this work include Circular RNAs in diseases (5 papers), Cancer-related Molecular Pathways (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (166 citations), Molecular Biology (363 citations) and Complementary and alternative medicine (42 citations). Lei Feng has collaborated with scholars based in China, United States and France. Frequent co-authors include S. Margolin, Shri N. Giri, Haiwei Meng, Yanxia Li, Mingqing Xu, Xiaobo Zheng, Chengwu Gu, Hangping Yao, Xiajing Tang and Ke Yao. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026